XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Total net revenue [1] $ 97,459 $ 98,826 $ 182,791 $ 188,403
Total cost of revenue [2] 56,628 60,926 106,557 117,560
Research and development [3] 11,956 13,064 24,104 26,405
Revenue from Joint Venture        
Total net revenue 4,632 2,643 9,583 6,460
Total cost of revenue 2,757 2,140 4,701 4,631
Research and development $ 430 $ 0 $ 430 $ 0
[1] Includes sales to the China joint venture, an equity method investment of $4,632 and $9,583 for the three and six months ended December 31, 2020 and $2,643 and $6,460 for the three and six months ended December 31, 2019, respectively. See Note 14.
[2] Includes cost of revenue from sales to the China joint venture, an equity method investment of $2,757 and $4,701 for the three and six months ended December 31, 2020, respectively, and of $2,140 and $4,631 for the three and six months ended December 31, 2019, respectively.
[3] Includes chargeback to the China joint venture, an equity method investment related to research and development project of $430 for the three and six months ended   December 31, 2020, respectively, and no chargeback for the three and six months ended December 31, 2019.